Literature DB >> 12668487

Beta-blockers in chronic heart failure.

Mihai Gheorghiade1, Wilson S Colucci, Karl Swedberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12668487     DOI： 10.1161/01.CIR.0000065187.80707.18

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  37 in total

1.  Heart failure-induced changes of voltage-gated Ca2+ channels and cell excitability in rat cardiac postganglionic neurons.

Authors:  Huiyin Tu; Jinxu Liu; Dongze Zhang; Hong Zheng; Kaushik P Patel; Kurtis G Cornish; Wei-Zhong Wang; Robert L Muelleman; Yu-Long Li
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

Review 2.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

3.  β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction.

Authors:  Biyi Chen; Yue Li; Shuxia Jiang; Yu-Ping Xie; Ang Guo; William Kutschke; Kathy Zimmerman; Robert M Weiss; Francis J Miller; Mark E Anderson; Long-Sheng Song
Journal:  FASEB J       Date:  2012-02-28       Impact factor: 5.191

Review 4.  Substrates and potential therapeutics of ventricular arrhythmias in heart failure.

Authors:  Dongze Zhang; Huiyin Tu; Michael C Wadman; Yu-Long Li
Journal:  Eur J Pharmacol       Date:  2018-06-27       Impact factor: 4.432

5.  Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure.

Authors:  Michael W Smith; Charnetta Brown; Salim S Virani; Charlene R Weir; Laura A Petersen; Natalie Kelly; Julia Akeroyd; Jennifer H Garvin
Journal:  Appl Clin Inform       Date:  2018-06-27       Impact factor: 2.342

6.  Renal sympathetic denervation for treatment of electrical storm: first-in-man experience.

Authors:  Christian Ukena; Axel Bauer; Felix Mahfoud; Jürgen Schreieck; Hans-Ruprecht Neuberger; Christian Eick; Paul A Sobotka; Meinrad Gawaz; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2011-09-29       Impact factor: 5.460

7.  Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.

Authors:  Michael Koutouzis; Savvas Nikolidakis; Anestis Grigoriadis; Dimitrios Koutsogeorgis; Zenon S Kyriakides
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart.

Authors:  Michael Huntgeburth; Karl La Rosée; Henrik ten Freyhaus; Michael Böhm; Petra Schnabel; Martin Hellmich; Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

9.  Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.

Authors:  Patricia McGettigan; Pearline Han; Lisa Jones; Diana Whitaker; David Henry
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

10.  Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.

Authors:  Robert O Bonow; Serenella Castelvecchio; Julio A Panza; Daniel S Berman; Eric J Velazquez; Robert E Michler; Lilin She; Thomas A Holly; Patrice Desvigne-Nickens; Dragana Kosevic; Miroslaw Rajda; Lukasz Chrzanowski; Marek Deja; Kerry L Lee; Harvey White; Jae K Oh; Torsten Doenst; James A Hill; Jean L Rouleau; Lorenzo Menicanti
Journal:  JACC Cardiovasc Imaging       Date:  2015-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.